Securing a strong intellectual property portfolio is of paramount importance for successful research and new product development in the biomedical sector. Ventac Partners brings a strong experience in the field having designed and implemented several intellectual property development campaigns for the benefit of its clients.
Our key competencies in this area include:
| Analysis of client’s intellectual property portfolio | |
| Management of the client’s intellectual property assets including collaboration with qualified legal counsels in a cost- and time-efficient manner | |
| Development of intellectual property generating strategies in agreement with clients’ business and revenue models | |
| Development of licensing strategies and negotiation of strategic deals essential to the clients’ commercialization efforts | |
Overall, our partners bring many years of collective experience in the field having executed several intellectual property related international business deals.
Peter Horn Moeller, PhD,
Partner
Patents are of greater commercial importance in the field of pharmaceuticals and biotechnology than in most other technical fields.
With our deep understanding of the competitive nature of the biomedical industry we advise universities as well as industry clients on all aspects of securing important intellectual property essential to capture the full value of a risk taking commercialization effort.
Robert L. Buchanan, PhD, Attorney at Law | Partner
For our clients, the remit of Ventac Partners is to contribute to the development and delivery of a coherent and effective international strategy for intellectual property development tailored to the need of the individual product, technology platform, university or company.
We put emphasis on how to manage an intellectual property strategy to maximize the value of your patent estate over time. And we advise our clients on how to take advantage of national legislation when designing their product development strategy.